The recent SCENIC Consensus statement has raised questions about which patients with chronic colitis should receive chromoendoscopic surveillance. Two papers in this issue of the American Journal of Gastroenterology provide more evidence and context, and this editorial discusses the current evidence base, which patients might benefit from chromoendoscopy, and what more evidence is needed before chromoendoscopy can be considered a possible new standard of care in all patients with chronic colitis.
1Department of Gastroenterology, University of Michigan, Ann Arbor, Michigan, USA
Correspondence: Peter D R Higgins, MD, PhD, MSc, Department of Gastroenterology, University of Michigan, 3912D Taubman Center, SPC 5682, 1650 West Medical Center Drive, Ann Arbor, Michigan 48109-5682, USA. E-mail: phiggins@umich.edu
Received 13 May 2015; accepted 18 May 2015
Guarantor of the article: Peter D.R. Higgins, MD, PhD, MSc.
Specific author contributions: Peter D.R. Higgins conceived, initiated, and wrote this editorial.
Financial support: None.
Potential competing interests: None.
